International Responsibility and the Health Impact Fund

Obi, Evaristus Chiedu

doi:10.1007/978-3-319-60028-4_5

Evaristus Chiedu Obi⁴

Part of the book series: Advancing Global Bioethics ((AGBIO,volume 7))

220 Accesses

Abstract

“Please check if identified section head levels are okay”.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 39.99; Price excludes VAT (USA)

Softcover Book: USD 54.99; Price excludes VAT (USA)

Hardcover Book: USD 54.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

1.
Thomas Pogge, “Cosmopolitanism and Sovereignty,” in Global Justice: Seminal Essays, ed. Thomas Pogge and Darrel Moellendorf (St. Paul, MN: Paragon House, 2008), 356.
2.
Mira Johri et al., “Sharing the Benefits of Medical Innovation: Ensuring Fair Access to Essential Medicines,” 2006, http://www.lawweb.usc.edu/centers/paccenter/assets/docs/Ehrenreich_Johri_2006_04_15.pdf. (Accessed March 20, 2014).
3.
Pogge, World Poverty and Human Rights: Cosmopolitan Responsibilities and Reforms, 145–146.
4.
Franklin Tennant Gairdner, “A Defence of Thomas Pogge’s Argument for a Minimally Just Institutional Order” (MA thesis, Queens’s University, 2009), 4.
5.
Pogge, “Assisting the Global poor,” 263.
6.
Thomas W. Pogge, “Human Rights and Global Health: A Research Program,” Metaphilosophy 36, no. 1/2, (January 2005): 182–183.
7.
Pogge, “Human Rights and Global Health: A Research Program,” 183.
8.
Pogge, “Human Rights and Global Health: A Research Program,” 183.
9.
Pogge, “Human Rights and Global Health: A Research Program,” 184.
10.
Pogge, “Human Rights and Global Health: A Research Program,” 184.
11.
Kok-Chor Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism (New York: Cambridge University Press, 2004), 1.
12.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 1.
13.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 1.
14.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 62.
15.
John Rawls, A Theory of Justice, Original Edition (Cambridge, Massachusetts: Harvard University Press, 1971), 15.
16.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 62.
17.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 62.
18.
Pogge, “Cosmopolitanism and Sovereignty,” 356.
19.
Charles Jones, Global Justice: Defending Cosmopolitanism (New York: Oxford University Press, 1999), 15.
20.
Paul Gomberg, “Patriotism is like Racism,” Ethics 101, no. 1 (October 1990): 144–150.
21.
Simon Keller, “Patriotism as Bad Faith,” Ethics 115, no. 3 (April 2005): 563–592.
22.
Jon Mandle, Global Justice (Malden, MA: Polity Press, 2006), 42.
23.
Mandle, Global Justice, 42.
24.
Charles R. Beitz, “International Liberalism and Distributive Justice: A Survey of Recent Thought,” World Politics 51, no. 2 (January 1999): 291.
25.
Mandle, Global Justice, 42.
26.
Robert E. Goodin, “What Is So Special about Our Fellow Countrymen,” in Global Justice: Seminal Essays, ed. Thomas Pogge and Darrel Moellendorf (St. Paul, MN: Paragon House, 2008), 255.
27.
Goodin, “What Is So Special about Our Fellow Countrymen,” 269.
28.
Jones, Global Justice: Defending Cosmopolitanism, 134.
29.
Darrel Moellendorf, Cosmopolitan Justice Reconsidered (Boulder, Colo.: Westview Press, 2002), 35.
30.
Thomas Pogge, “An Egalitarian Law of Peoples”, Philosophy and Public Affairs 23, no. 3 (Summer 1994): 202.
31.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 37.
32.
Brian Barry, “Justice as Reciprocity”, in Liberty and Justice: Essays in Political Theory, Volume 2 (Oxford: Clarendon, 1991), 239–240.
33.
Brian Barry, “International Society from a Cosmopolitan Perspective” in International Society: Diverse Ethical Perspectives ed. David Mapel and Terry Nardin (Princeton: Princeton University Press, 1998), 159–160.
34.
Joseph Millum, “Global Bioethics and Political Theory” in Global Justice and Bioethics ed. Joseph Millum and Ezekiel J. Emmanuel (New York: Oxford University Press, 2012), 20–21.
35.
Millum, “Global Bioethics and Political Theory”, 21.
36.
Charles Beitz, Political Theory and International Relations (Princeton, NJ: Princeton University Press, 1999), 182–183.
37.
Pogge, “Cosmopolitanism and Sovereignty,” 356.
38.
Pogge, “Cosmopolitanism and Sovereignty,” 357–364.
39.
Pogge, “Cosmopolitanism and Sovereignty,” 357.
40.
Pogge, “Cosmopolitanism and Sovereignty,” 357.
41.
Pogge, “Cosmopolitanism and Sovereignty,” 359.
42.
Martha C. Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, Oxford Development Studies 32, no. 1 (March 2004): 10–11.
43.
Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, 11.
44.
Beitz, Political Theory and International Relations, 136–143.
45.
Beitz, Political Theory and International Relations, 141.
46.
Beitz, Political Theory and International Relations, 144–152.
47.
Beitz, Political Theory and International Relations, 154.
48.
Simon Caney, Justice Beyond Borders: A Global Political Theory (New York: Oxford University Press, 2005), 109.
49.
Brain Barry, “Humanity and Justice in Global Perspective” in Global Justice: Seminal Essays, ed. Thomas Pogge and Darrel Moellendorf (St. Paul, MN: Paragon House, 2008), 191.
50.
Barry, “Humanity and Justice in Global Perspective” 191–192.
51.
Beitz, Political Theory and International Relations, 131.
52.
Beitz, Political Theory and International Relations, 150.
53.
David A.J. Richards, “International Distributive Justice” in Ethics, Economics, and the Law: NOMOS XXIV ed. J. Roland Pennock and John W. Chapman (New York: New York University Press, 1982), 278–282.
54.
Richards, “International Distributive Justice” 290.
55.
Caney, Justice Beyond Borders: A Global Political Theory, 115.
56.
Charles Beitz, “Cosmopolitan Ideals and National Sentiment”, The Journal of Philosophy 80, no. 10 (October 1983): 595.
57.
Charles R. Beitz, “Social and Cosmopolitan Liberalism”, International Affairs 75, no. 3 (July 1999): 521–524.
58.
Caney, Justice Beyond Borders: A Global Political Theory, 110.
59.
Caney, Justice Beyond Borders: A Global Political Theory, 111.
60.
Darrel Moellendorf, Cosmopolitan Justice (Boulder, Colorado: Westview Press, 2002), 30–36.
61.
Moellendorf, Cosmopolitan Justice, 36–38.
62.
Thomas Pogge, “Eradicating Systematic Poverty: Brief for a Global Resources Dividend” in World Poverty and Human Rights: Cosmopolitan Responsibilities and Reforms (Cambridge: Polity Press, 2002), 197.
63.
Thomas W. Pogge, Realizing Rawls (Ithaca, NY: Cornell University Press, 1989), 276–278.
64.
Henry Shue, Basic Rights: Subsistence, Affluence, and U.S. Foreign Policy, Second Edition (Princeton: Princeton University Press, 1996), 164–166.
65.
Thomas Pogge, “A Global Resources Dividend” in Ethics of Consumption: The Good Life, Justice, and Global Stewardship ed. David A. Crocker and Toby Linden (Lanham: Rowman and Littlefield, 1998), 501–536.
66.
Pogge, “An Egalitarian Law of Peoples”, 201.
67.
Pogge, “An Egalitarian Law of Peoples”, 201–202.
68.
Onora O’Neill, Bounds of Justice (New York: Cambridge University Press, 2000), 122.
69.
Peter Singer, “Famine, Affluence and Morality”, Philosophy and Public Affairs 1, no. 3 (Spring 1972): 229–230.
70.
Peter Singer, “Famine, Affluence and Morality”, 231.
71.
Singer, “Famine, Affluence and Morality”, 231.
72.
Singer, “Famine, Affluence and Morality”, 231.
73.
Singer, “Famine, Affluence and Morality”, 231.
74.
Singer, “Famine, Affluence and Morality”, 232.
75.
Singer, “Famine, Affluence and Morality”, 231–234.
76.
Singer, “Famine, Affluence and Morality”, 235–237.
77.
John Arthur, “Rights and the Duty to Bring Aid” in World Hunger and Morality ed. W. Aiken and H. LaFollette 2nd Edition (Englewood Cliffs, NJ: Prentice Hall, 1996), 43–44.
78.
Deborah Zion, “HIV/AIDS Clinical Research and the Claims of Beneficence, Justice and Integrity”, Cambridge Quarterly of Healthcare Ethics 13, no. 4 (October 2004): 407.
79.
Michael Slote, “The Morality of Wealth” in World Hunger and Moral Obligation ed. W. Aiken and H. LaFollette (Englewood Cliffs, NJ: Prentice Hall, 1997), 125–127.
80.
Zion, “HIV/AIDS Clinical Research and the Claims of Beneficence, Justice and Integrity”, 407.
81.
Caney, Justice Beyond Borders: A Global Political Theory, 116–117.
82.
Robert E. Goodin, Protecting the Vulnerable: A Reanalysis of our Social Responsibilities (Chicago: University of Chicago Press, 1985), 33–144.
83.
Goodin, Protecting the Vulnerable: A Reanalysis of our Social Responsibilities, 161–169.
84.
Goodin, Protecting the Vulnerable: A Reanalysis of our Social Responsibilities, 159–161.
85.
Goodin, Protecting the Vulnerable: A Reanalysis of our Social Responsibilities, 161–164.
86.
Caney, Justice Beyond Borders: A Global Political Theory, 117.
87.
Goodin, Protecting the Vulnerable: A Reanalysis of our Social Responsibilities, 163.
88.
Goodin, Protecting the Vulnerable: A Reanalysis of our Social Responsibilities, 164.
89.
Zion, “HIV/AIDS Clinical Research and the Claims of Beneficence, Justice and Integrity”, 407.
90.
Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, 13.
91.
Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, 13.
92.
Caney, Justice Beyond Borders: A Global Political Theory, 118.
93.
Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, 13.
94.
Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, 13.
95.
Nussbaum, “Beyond the Social Contract: Capabilities and Global Justice”, 13.
96.
Caney, Justice Beyond Borders: A Global Political Theory, 118.
97.
Shue, Basic Rights: Subsistence, Affluence, and U.S. Foreign Policy, 22–27.
98.
Jones, Global Justice: Defending Cosmopolitanism, 50–84.
99.
Shue, Basic Rights: Subsistence, Affluence, and U.S. Foreign Policy, 18–20.
100.
Shue, Basic Rights: Subsistence, Affluence, and U.S. Foreign Policy, 26–27.
101.
Shue, Basic Rights: Subsistence, Affluence, and U.S. Foreign Policy, 27.
102.
Shue, Basic Rights: Subsistence, Affluence, and U.S. Foreign Policy, 23.
103.
Jones, Global Justice: Defending Cosmopolitanism, 56–57.
104.
Jones, Global Justice: Defending Cosmopolitanism, 59–61.
105.
Caney, Justice Beyond Borders: A Global Political Theory, 120.
106.
Caney, Justice Beyond Borders: A Global Political Theory, 120.
107.
Caney, Justice Beyond Borders: A Global Political Theory, 120.
108.
David Held, Democracy and the Global Order: From the Modern State to Cosmopolitan Governance (Cambridge: Polity Press, 1995), 192–194.
109.
Held, Democracy and the Global Order: From the Modern State to Cosmopolitan Governance, 192, 194–195.
110.
Held, Democracy and the Global Order: From the Modern State to Cosmopolitan Governance, 192, 195.
111.
Held, Democracy and the Global Order: From the Modern State to Cosmopolitan Governance, 193, 197–198.
112.
Pogge, “A Global Resources Dividend”, 501.
113.
Pogge, “Cosmopolitanism and Sovereignty,” 356–364.
114.
O’Neill, Bounds of Justice, 126.
115.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 49.
116.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 49.
117.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 49.
118.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 49.
119.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 50.
120.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 50.
121.
O’Neill, Bounds of Justice, 126.
122.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 50.
123.
Tan, Justice Without Borders: Cosmopolitanism, Nationalism and Patriotism, 50.
124.
Onora O’Neill, Constructions of Reason: Exploration of Kant’s Practical Philosophy (New York: St Martin’s Press, 1989), 191.
125.
O’Neill, Bounds of Justice, 126.
126.
O’Neill, Constructions of Reason: Exploration of Kant’s Practical Philosophy, 199.
127.
O’Neill, Bounds of Justice, 136.
128.
O’Neill, Bounds of Justice, 140–141.
129.
O’Neill, Bounds of Justice, 125.
130.
Christina Jones-Pauly, “Loosening the Bounds of Human Rights: Global Justice and the Theory of Justice,” Human Rights and Human Welfare 1, no. 3 (July 2001): 19.
131.
Jones-Pauly, “Loosening the Bounds of Human Rights: Global Justice and the Theory of Justice,” 19.
132.
Jones-Pauly, “Loosening the Bounds of Human Rights: Global Justice and the Theory of Justice,” 19.
133.
O’Neill, Bounds of Justice, 174.
134.
Jones-Pauly, “Loosening the Bounds of Human Rights: Global Justice and the Theory of Justice,” 19.
135.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 244.
136.
Pogge, “Human Rights and Global Health: A Research Program,” 182.
137.
WHO and WTO, WTO Agreements & Public Health: A Joint Study by the WHO and the WTO Secretariat (Geneva, Switzerland: WHO and WTO, 2002), 39.
138.
WHO, Medicines and the Idea of Essential Drugs (EDM), (Geneva, Switzerland: WHO, 2004), http://www.who.int/medicines/rationale.shtml. (Accesed May 16, 2014).
139.
Pogge, “Human Rights and Global Health: A Research Program,” 182–209.
140.
Thomas Pogge, “Severe Poverty as a Violation of Negative Duties,” Ethics & International Affairs 19, no.1 (March 2005): 55.
141.
Pogge, “Severe Poverty as a Violation of Negative Duties,” 55.
142.
Pogge, “Eradicating Systematic Poverty: Brief for a Global Resources Dividend” 203.
143.
Pogge, World Poverty and Human Rights: Cosmopolitan Responsibilities and Reforms, 26–27.
144.
Mira Johri et al., “Sharing the Benefits of Medical Innovation: Ensuring Fair Access to Essential Medicines,” 2006, http://www.lawweb.usc.edu/centers/paccenter/assets/docs/Ehrenreich_Johri_2006_04_15.pdf. (Accessed March 20, 2014).
145.
Carsten Fink and Patrick Reichenmiller, Tightening TRIPS: Intellectual Property Provisions of U.S. Free Trade Agreements (Washington, DC: World Bank, 2005), 1–2.
146.
Mira Johri et al., “Sharing the Benefits of Medical Innovation: Ensuring Fair Access to Essential Medicines,” 2006, http://www.lawweb.usc.edu/centers/paccenter/assets/docs/Ehrenreich_Johri_2006_04_15.pdf. (Accessed March 20, 2014).
147.
Pogge, “Human Rights and Global Health: A Research Program,” 197–198.
148.
Pogge, “Human Rights and Global Health: A Research Program,” 198.
149.
Pogge, “Human Rights and Global Health: A Research Program,” 198.
150.
Pogge, “Human Rights and Global Health: A Research Program,” 198.
151.
Pogge, “Human Rights and Global Health: A Research Program,” 199.
152.
Pogge, “Human Rights and Global Health: A Research Program,” 199.
153.
Jorn Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions (Washington, DC: World Bank and Human Development Network, 2010), 2–3.
154.
Pogge, “Human Rights and Global Health: A Research Program,” 184.
155.
David Barnard, “In the High Court of South Africa, Case No. 4138/98: The Global Politics of Access to Low-Cost AIDS Drugs in Poor Countries,” Kennedy Institute of Ethics Journal 12, no. 2 (June 2002): 159–174.
156.
Pogge, “Human Rights and Global Health: A Research Program,” 185.
157.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 3.
158.
Pogge, “Human Rights and Global Health: A Research Program,” 186.
159.
Pogge, “Human Rights and Global Health: A Research Program,” 186.
160.
Thomas Pogge, “Access to Medicines,” Public Health Ethics 1, no. 2 (July 2008): 75.
161.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 4.
162.
Pogge, “Human Rights and Global Health: A Research Program,” 186.
163.
Michael Ravvin, “Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions,” Public Health Ethics 1, no. 2 (2008): 112.
164.
Ravvin, “Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions,” 116.
165.
Pogge, “Human Rights and Global Health: A Research Program,” 187.
166.
Michael J. Selgelid, “A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues,” Public Health Ethics 1, no. 2 (July 2008): 134.
167.
David B. Ridley, Henry G. Grabowski and Jeffrey L. Moe, “Developing Drugs for Developing Countries,” Health Affairs 25, no. 2 (March 2006): 316.
168.
Patrice Trouiller et al., “Drugs for Neglected Diseases: A Failure of the Market and a Public Health Failure?”, Tropical Medicine and International Health 6, no. 11 (November 2001): 945–951.
169.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 5.
170.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 6.
171.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 6.
172.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 6.
173.
Pogge, Politics as Usual: What Lies Behind The Pro-Poor Rhetoric, 20–21.
174.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 246.
175.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 246–247.
176.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 246.
177.
Oxfam International, “Investing for Life: Meeting Poor People’s Needs for Access to Medicines through Responsible Business Practices,” Briefing Paper no. 109 (November 2007): 20, http://www.oxfam.org/en/policy/bp109_investing_for_life_0711 (Accessed May 21, 2014).
178.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 246.
179.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 246.
180.
Global Forum for Health Research, The 10/90 Report on Health Research 2003-2004 (Geneva: GFHR, 2004), http://www.globalforumhealth.org (Accessed May 21, 2014).
181.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
182.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
183.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
184.
Aidan Hollis, An Efficient Reward System for Pharmaceutical Innovation, Working Paper (Calgary: Department of Economics, University of Calgary, 2005), 8. http://www.econ.ucalgary.ca/fac-files/ah/drugprizes.pdf (Accessed May 22, 2014).
185.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
186.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
187.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
188.
Thomas Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” in World Poverty and Human Rights: Cosmopolitan Responsibilities and Reforms, Second Edition (Cambridge: Polity Press, 2008), 138.
189.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 238.
190.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 6.
191.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 6–7.
192.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 238–239.
193.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 7.
194.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 239.
195.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 239.
196.
Ravvin, “Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions,” 114.
197.
James Love and Tim Hubbard, “The Big Idea: Prizes to Stimulate R&D for New Medicines,” Chicago-Kent Law Review 82, no. 3 (November 2007): 1519–1554.
198.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 239.
199.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 240.
200.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 240.
201.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 240.
202.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 240.
203.
Love and Hubbard, “The Big Idea: Prizes to Stimulate R&D for New Medicines,” 1525.
204.
Jerome H. Reichman, “Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options,” The Journal of Law, Medicine & Ethics 37, no. 2 (Summer 2009): 248.
205.
Josephine Johnston and Angela A. Wasunna, “Patents, Biomedical Research, and Treatments: Examining Concerns, Canvassing Solutions,” The Hastings Center Report 37, no. 1 (January-February 2007): 18.
206.
Matthew Rimmer, “Race Against Time: The Export of Essential Medicines to Rwanda,” Public Health Ethics 1, no. 2 (August 2008): 89.
207.
Robert C. Bird, “Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines while Minimizing Investment Side Effects,” Journal of Law, Medicine & Ethics 37, no. 2 (Summer 2009): 209.
208.
Bird, “Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines while Minimizing Investment Side Effects,” 209–221.
209.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 240.
210.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 240.
211.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 241.
212.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 241.
213.
Pogge, “Human Rights and Global Health: A Research Program,” 188–189.
214.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 241.
215.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 241–242.
216.
Pogge, “Pharmaceutical Innovation: Must We Exclude the Poor?” 242.
217.
Pogge, “Human Rights and Global Health: A Research Program,” 189.
218.
Pogge, “Human Rights and Global Health: A Research Program,” 189–191.
219.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 26.
220.
Pogge, “Human Rights and Global Health: A Research Program,” 191.
221.
Pogge, “Human Rights and Global Health: A Research Program,” 192.
222.
Pogge, “Human Rights and Global Health: A Research Program,” 191.
223.
Aidan Hollis and Thomas Pogge, The Health Impact Fund: Making New Medicines Accessible for All (New Haven, CT: Incentives for Global Health, 2008), 44.
224.
Pogge, “Human Rights and Global Health: A Research Program,” 192.
225.
Pogge, “Human Rights and Global Health: A Research Program,” 192.
226.
Pogge, “Human Rights and Global Health: A Research Program,” 193.
227.
Pogge, “Human Rights and Global Health: A Research Program,” 193.
228.
Thomas Pogge, The Health Impact Fund: More Justice and Efficiency in Global Health, Development Policy Center Discussion Paper 7, Crawford School of Economic and Government (Cranberra: The Australian National University, 2011), http://devpolicy.anu.edu.au/pdf/papers/DP7_The_Health_Impact_Fund_More_justice_and_efficiency_in_global_health.pdf (Accessed May 26, 2014).
229.
Pogge, The Health Impact Fund: More Justice and Efficiency in Global Health, http://devpolicy.anu.edu.au/pdf/papers/DP7_The_Health_Impact_Fund_More_justice_and_efficiency_in_global_health.pdf (Accessed May 26, 2014).
230.
Thomas Pogge, “The Health Impact Fund: Enduring Innovation Incentives for Cost-Effective Health Gains,” Social Europe Journal 5, no. 2 (June 2011): 5-9. http://www.social-europe.eu/2011/01/the-health-impact-fund-enduring-innovation-incentiv. (Accessed May 26, 2014).
231.
Pogge, “The Health Impact Fund: Enduring Innovation Incentives for Cost-Effective Health Gains,” http://www.social-europe.eu/2011/01/the-health-impact-fund-enduring-innovation-incentiv. (Accessed May 26, 2014).
232.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 248.
233.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 248.
234.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 248.
235.
Kathleen Liddell, “The Health Impact Fund: A Critique,” in Incentives for Global Public Health: Patent Law and Access to Essential Medicines, ed. Thomas Pogge, Matthew Rimmer and Kim Rubenstein (New York: Cambridge University Press, 2010), 158–159.
236.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 248.
237.
Aidan Hollis, Incentive Mechanisms for Innovation, IAPR Technical Paper, (Calgary: University of Calgary, 2007), 15–16, http://www.iapr.ca/iapr/files/iapr/iapr.-tp-07005_0.pdf (Accessed May 26, 2014).
238.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 248.
239.
Pogge, “The Health Impact Fund: How to Make New Medicines Accessible to All,” 247.
240.
Thomas Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” in Incentives for Global Public Health: Patent Law and Access to Essential Medicines, ed. Thomas Pogge, Matthew Rimmer and Kim Rubenstein (New York: Cambridge University Press, 2010), 151–152.
241.
Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” 152.
242.
Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” 152.
243.
Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” 152.
244.
Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” 152.
245.
Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” 152–153.
246.
Pogge, “The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices,” 153.
247.
Jorn Sonderholm, “A Reform Proposal in Need of Reform: A Critique of Thomas Pogge’s Proposal for How to Incentivize Research and Development of Essential Drugs,” Public Health Ethics 3, no. 2 (January 2010): 167–177.
248.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 27.
249.
Alex Rosenberg, “On the Priority of Intellectual Property Rights, Especially in Biotechnology,” Politics, Philosophy & Economics 3, no. 1 (February 2004): 84.
250.
Hollis and Pogge, The Health Impact Fund: Making New Medicines Accessible for All, 31.
251.
Johann Graf Lambsdorff, Corruption Perceptions Index (CPI), Transparency International 2008. http://transparency.org/news_room/latest_news/press_releases/2008/2008_09_23_cpi_20008_en. (Accessed May 27, 2014).
252.
Hollis and Pogge, The Health Impact Fund: Making New Medicines Accessible for All, 31.
253.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 28.
254.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 28.
255.
Ravvin, “Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions,” 120.
256.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 28.
257.
Liddell, “The Health Impact Fund: A Critique,” 161–162.
258.
Liddell, “The Health Impact Fund: A Critique,” 179.
259.
Liddell, “The Health Impact Fund: A Critique,” 179.
260.
Liddell, “The Health Impact Fund: A Critique,” 179.
261.
Liddell, “The Health Impact Fund: A Critique,” 180.
262.
Sonderholm, “A Reform Proposal in Need of Reform: A Critique of Thomas Pogge’s Proposal for How to Incentivize Research and Development of Essential Drugs,” 167–177.
263.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 29.
264.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 30.
265.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 30.
266.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 30.
267.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 30.
268.
Sonderholm, “A Reform Proposal in Need of Reform: A Critique of Thomas Pogge’s Proposal for How to Incentivize Research and Development of Essential Drugs,” 167–177.
269.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 30–31.
270.
Selgelid, “A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues,” 140.
271.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 31.
272.
Sonderholm, Intellectual Property Rights and the TRIPS Agreement: An Overview of Ethical Problems and Some Proposed Solutions, 32.

Author information

Authors and Affiliations

Duquesne University, Pittsburgh, PA, USA
Evaristus Chiedu Obi

Authors

Evaristus Chiedu Obi
View author publications
You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Obi, E.C. (2017). International Responsibility and the Health Impact Fund. In: Post-Trial Access to Drugs in Developing Nations. Advancing Global Bioethics, vol 7. Springer, Cham. https://doi.org/10.1007/978-3-319-60028-4_5

Download citation

DOI: https://doi.org/10.1007/978-3-319-60028-4_5
Published: 28 July 2017
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60026-0
Online ISBN: 978-3-319-60028-4
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)

Publish with us

Policies and ethics